OBJECTIVE: To demonstrate that nosocomial transmission of vancomycin-resistant enterococci (VRE) can be terminated and endemicity prevented despite widespread dissemination of an epidemic strain in a large tertiary-care referral hospital. INTERVENTIONS: Two months after the index case was detected in the intensive care unit, 68 patients became either infected or colonized with an epidemic strain of vanB vancomycin-resistant Enterococcus faecium despite standard infection control procedures. The following additional interventions were then introduced to control the outbreak: (1) formation of a VRE executive group; (2) rapid laboratory identification (30 to 48 hours) using culture and polymerase chain reaction detection of vanA and vanB resistance genes; (3) mass screening of all hospitalized patients with isolation of carriers and cohorting of contacts; (4) environmental screening and increased cleaning; (5) electronic flagging of medical records of contacts; and (6) antibiotic restrictions (third-generation cephalosporins and vancomycin). RESULTS: A total of 19,658 patient and 24,396 environmental swabs were processed between July and December 2001. One hundred sixty-nine patients in 23 wards were colonized with a single strain of vanB vancomycin-resistant E. faecium. Introducing additional control measures rapidly brought the outbreak under control. Hospital-wide screening found 39 previously unidentified colonized patients, with only 7 more nonsegregated patients being detected in the next 2 months. The outbreak was terminated within 3 months at a cost of dollar 2.7 million (Australian dollars). CONCLUSION: Despite widespread dissemination of VRE in a large acute care facility, eradication was achievable by a well-resourced, coordinated, multifaceted approach and was in accordance with good clinical governance.
OBJECTIVE: To demonstrate that nosocomial transmission of vancomycin-resistant enterococci (VRE) can be terminated and endemicity prevented despite widespread dissemination of an epidemic strain in a large tertiary-care referral hospital. INTERVENTIONS: Two months after the index case was detected in the intensive care unit, 68 patients became either infected or colonized with an epidemic strain of vanBvancomycin-resistant Enterococcus faecium despite standard infection control procedures. The following additional interventions were then introduced to control the outbreak: (1) formation of a VRE executive group; (2) rapid laboratory identification (30 to 48 hours) using culture and polymerase chain reaction detection of vanA and vanB resistance genes; (3) mass screening of all hospitalized patients with isolation of carriers and cohorting of contacts; (4) environmental screening and increased cleaning; (5) electronic flagging of medical records of contacts; and (6) antibiotic restrictions (third-generation cephalosporins and vancomycin). RESULTS: A total of 19,658 patient and 24,396 environmental swabs were processed between July and December 2001. One hundred sixty-nine patients in 23 wards were colonized with a single strain of vanBvancomycin-resistant E. faecium. Introducing additional control measures rapidly brought the outbreak under control. Hospital-wide screening found 39 previously unidentified colonized patients, with only 7 more nonsegregated patients being detected in the next 2 months. The outbreak was terminated within 3 months at a cost of dollar 2.7 million (Australian dollars). CONCLUSION: Despite widespread dissemination of VRE in a large acute care facility, eradication was achievable by a well-resourced, coordinated, multifaceted approach and was in accordance with good clinical governance.
Authors: Thamara M Wijesuriya; Peta Perry; Todd Pryce; John Boehm; Ian Kay; James Flexman; Geoffrey W Coombs; Paul R Ingram Journal: J Clin Microbiol Date: 2014-05-28 Impact factor: 5.948
Authors: Ana R Freitas; Ana P Tedim; Carla Novais; Patricia Ruiz-Garbajosa; Guido Werner; Jenny A Laverde-Gomez; Rafael Cantón; Luísa Peixe; Fernando Baquero; Teresa M Coque Journal: Antimicrob Agents Chemother Date: 2010-04-12 Impact factor: 5.191
Authors: Geoffrey W Coombs; Julie C Pearson; Denise A Daley; Tam Le; Owen J Robinson; Thomas Gottlieb; Benjamin P Howden; Paul D R Johnson; Catherine M Bennett; Timothy P Stinear; John D Turnidge Journal: J Clin Microbiol Date: 2014-01-03 Impact factor: 5.948
Authors: Sheila M Nolan; Jeffrey S Gerber; Theoklis Zaoutis; Priya Prasad; Susan Rettig; Kimberly Gross; Karin L McGowan; Anne F Reilly; Susan E Coffin Journal: Infect Control Hosp Epidemiol Date: 2009-04 Impact factor: 3.254
Authors: Young Kyung Yoon; Hee Sun Sim; Jeong Yeon Kim; Dae Won Park; Jang Wook Sohn; Kyung Ho Roh; Seung Eun Lee; Min Ja Kim Journal: Yonsei Med J Date: 2009-10-21 Impact factor: 2.759
Authors: Matthew C Exline; Naeem A Ali; Nancy Zikri; Julie E Mangino; Kelly Torrence; Brenda Vermillion; Jamie St Clair; Mark E Lustberg; Preeti Pancholi; Madhuri M Sopirala Journal: Crit Care Date: 2013-03-04 Impact factor: 9.097